GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Greenrose Holding Co (OTCPK:GNRS) » Definitions » EV-to-EBIT

The Greenrose Holding Co (The Greenrose Holding Co) EV-to-EBIT : -3.89 (As of May. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is The Greenrose Holding Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, The Greenrose Holding Co's Enterprise Value is $140.93 Mil. The Greenrose Holding Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-36.18 Mil. Therefore, The Greenrose Holding Co's EV-to-EBIT for today is -3.89.

The historical rank and industry rank for The Greenrose Holding Co's EV-to-EBIT or its related term are showing as below:

GNRS's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.955
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. The Greenrose Holding Co's Enterprise Value for the quarter that ended in Sep. 2022 was $161.09 Mil. The Greenrose Holding Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-36.18 Mil. The Greenrose Holding Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -22.46%.


The Greenrose Holding Co EV-to-EBIT Historical Data

The historical data trend for The Greenrose Holding Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Greenrose Holding Co EV-to-EBIT Chart

The Greenrose Holding Co Annual Data
Trend Dec19 Dec20 Dec21
EV-to-EBIT
- 14.12 -

The Greenrose Holding Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.30 - -174.03 -21.30 -4.45

Competitive Comparison of The Greenrose Holding Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, The Greenrose Holding Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Greenrose Holding Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Greenrose Holding Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where The Greenrose Holding Co's EV-to-EBIT falls into.



The Greenrose Holding Co EV-to-EBIT Calculation

The Greenrose Holding Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=140.930/-36.184
=-3.89

The Greenrose Holding Co's current Enterprise Value is $140.93 Mil.
The Greenrose Holding Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-36.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Greenrose Holding Co  (OTCPK:GNRS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

The Greenrose Holding Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2022 ) =EBIT / Enterprise Value (Q: Sep. 2022 )
=-36.184/161.086962
=-22.46 %

The Greenrose Holding Co's Enterprise Value for the quarter that ended in Sep. 2022 was $161.09 Mil.
The Greenrose Holding Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-36.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Greenrose Holding Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of The Greenrose Holding Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


The Greenrose Holding Co (The Greenrose Holding Co) Business Description

Traded in Other Exchanges
Address
111 Broadway, Amityville, NY, USA, 11701
The Greenrose Holding Co is engaged in the manufacture and processing of cannabis in the adult-use and medical cannabis marketplace in Connecticut and Arizona.
Executives
Bernard Wang officer: CHIEF FINANCIAL OFFICER 5575 TERRACE DR., LA CRESCENTA CA 91214
Benjamin Rose director 10115 JEFFERSON BOULEVARD, CULVER CITY CA 90232
True Harvest, Llc 10 percent owner 4216 N. 43RD STREET, PHOENIX AZ 85018
Michael Macchiaroli 10 percent owner 4216 N. 43RD STREET, PHOENIX AZ 85018
Scott Jeffrey Cohen officer: Chief Financial Officer C/O GREENROSE ASSOCIATES LLC, 111 BROADWAY, AMITYVILLE NY 11701
Greenrose Associates Llc 10 percent owner 1000 WESTBURY AVENUE, WESTBURY NY 11590
Steven Francis Cummings director, 10 percent owner 1000 WOODBURY ROAD, SUITE 212, WOODBURY NY 11797
Daniel Patrick Harley director, 10 percent owner, officer: Executive Vice-President 1000 WOODBURY ROAD, SUITE 212, WOODBURY NY 11797
John Iii Torrance director, 10 percent owner 1000 WOODBURY ROAD, WOODBURY NY 11797
Thomas J Megale director 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
John Falcon director, 10 percent owner 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
Jeffrey Stegner 10 percent owner, officer: Chief Financial Officer 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
Brendan Sheehan director, 10 percent owner, officer: Executive Vice-President 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
William Iii Harley director, 10 percent owner, officer: Chief Executive Officer 1000 WOODBURY ROAD, WOODBURY NY 11797
Paul Otto Wimer 10 percent owner, officer: President 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797

The Greenrose Holding Co (The Greenrose Holding Co) Headlines